Next Article in Journal
Molecular Dynamics Simulations of Matrix Metalloproteinase 13 and the Analysis of the Specificity Loop and the S1′−Site
Previous Article in Journal
Effect of Silicon on Micronutrient Content in New Potato Tubers
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Direct Effects of Toxic Divalent Cations on Contractile Proteins with Implications for the Heart: Unraveling Mechanisms of Dysfunction

by
Oksana P. Gerzen
*,
Veronika O. Votinova
,
Iulia K. Potoskueva
,
Alyona E. Tzybina
and
Larisa V. Nikitina
Institute of Immunology and Physiology of the Ural Branch of the Russian Academy of Sciences, 620049 Ekaterinburg, Russia
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2023, 24(13), 10579; https://doi.org/10.3390/ijms241310579
Submission received: 14 May 2023 / Revised: 19 June 2023 / Accepted: 22 June 2023 / Published: 24 June 2023
(This article belongs to the Special Issue Muscle Proteins: Recent Advances and Prospects)

Abstract

:
The binding of calcium and magnesium ions to proteins is crucial for regulating heart contraction. However, other divalent cations, including xenobiotics, can accumulate in the myocardium and enter cardiomyocytes, where they can bind to proteins. In this article, we summarized the impact of these cations on myosin ATPase activity and EF-hand proteins, with special attention given to toxic cations. Optimal binding to EF-hand proteins occurs at an ionic radius close to that of Mg2+ and Ca2+. In skeletal Troponin C, Cd2+, Sr2+, Pb2+, Mn2+, Co2+, Ni2+, Ba2+, Mg2+, Zn2+, and trivalent lanthanides can substitute for Ca2+. As myosin ATPase is not a specific MgATPase, Ca2+, Fe2+, Mn2+, Ni2+, and Sr2+ could support myosin ATPase activity. On the other hand, Zn2+ and Cu2 significantly inhibit ATPase activity. The affinity to various divalent cations depends on certain proteins or their isoforms and can alter with amino acid substitution and post-translational modification. Cardiac EF-hand proteins and the myosin ATP-binding pocket are potential molecular targets for toxic cations, which could significantly alter the mechanical characteristics of the heart muscle at the molecular level.

1. Introduction

Heart contraction is a highly coordinated and complex process that involves the interplay of thin and thick filaments, which slide one past another with no alteration in their length [1]. The thick filament primarily consists of myosin molecules, which contain two heavy and four light chains, including two calcium-binding regulatory and two non-calcium-binding essential light chains [2]. The thin filament comprises actin, tropomyosin, and troponin subunits T, I, and C [3].
The concentration of intracellular calcium plays a crucial role in regulating heart contraction by binding calcium ions to the troponin C subunit and altering the structure of troponin [4]. This causes the tropomyosin strands to move across the actin filament, opening sites for binding with myosin heads—the N-terminus of myosin heavy chains [5]. The energy required for myosin to propel thin filaments is provided by ATP hydrolysis [6] in the myosin ATP-binding pocket, which can also bind magnesium ions [7].
In summary, heart contraction involves multiple proteins, including calcium- and magnesium-binding protein structures, viz. troponin C, the myosin regulatory light chain, and the ATP-binding pocket of myosin [8,9,10]. Calcium and magnesium are involved in a complex cascade of protein interactions during heart contraction, in which timing and coordination are highly important for the entire process. Therefore, calcium and magnesium ions play an essential role in regulating actomyosin interaction during heart contraction. However, is it possible for other cations to intervene in this well-orchestrated process?

2. Accumulation, Competition, and Toxicity of Divalent Cations

2.1. Accumulation in the Myocardium and Cardiotoxic Effect of Divalent Cations

Myocardium was found to accumulate various chemicals, such as aluminium [11,12,13,14], antimony [15], barium [11], cadmium [11,16,17,18,19,20,21,22,23,24,25,26], calcium [27,28,29], caesium [11], cobalt [15,18], copper [11,18,27,28,29,30,31,32], chromium [11,15,27,33], gold [15], iron [27,28,34], lead [11,18,19,22,35], magnesium [28,29], manganese [11,18,27,28,36], mercury [15,16], molybdenum [11,28], nickel [11,18,27,33,34,37,38], strontium [11,27], tin [11], and zinc [11,17,18,19,20,22,27,28,29,32]. Amongst them, there are elements with the primary oxidation state of +2.
The above-mentioned divalent cations can be divided into three groups [39,40,41]:
  • Essential ions for physiological processes (Ca2+, Cu2+, Fe2+, Mg2+, Zn2+, Mo2+).
  • Nonessential ions with no or low or unknown toxicity (Ba2+, Sr2+, Co2+, Ni2+).
  • Nonessential and highly toxic ions (Cd2+, Pb2+, Hg2+).
Some other less toxic mono-, di-, and trivalent cations also tend to accumulate in the myocardium and have been used as calcium analogues in various studies, e.g., La3+ and Tb3+ have been widely used as Ca2+ surrogates to examine metal binding properties and conformational changes of Troponin C [39,40,42].
Nevertheless, we focused on the nonessential toxic divalent cations from the 3rd group viz. Cd2+, Pb2+, and Hg2+, which are ubiquitous chemicals and considered to be important co-exposures [43]. Chronic exposure to cadmium [44,45], lead [46,47,48], and mercury [49] has been associated with multiple cardiovascular diseases. Cardiotoxicity after chronic and acute exposure was experimentally confirmed in the animal models for cadmium [16,50,51,52,53,54], lead [19,35,55,56,57], and mercury [16]. For each of viz. cadmium [58,59,60,61], lead [40,62,63], and mercury [40,64,65], the direct cardiotoxic effect was confirmed at different levels of organization, including the whole heart, multicellular, cellular, and protein level.
It is worth noting that excess of some essential divalent cations from the 1st and 2nd groups could also be highly toxic. For example, Cu2+ could have mediated toxic effects through chronic exposure [31] and direct toxic effects [66,67,68] on the cardiovascular system. Ni2+ [69,70,71] and V2+ [69,71] exposure could also be connected with cardiovascular diseases (CVD). Co-exposure to Cu2+, Mo2+ and V2+ could be closely connected with CVD mortality [72]. Other essential cations like Ba2+, Mn2+, Co2+, Ni2+, and Zn2+ could have a direct effect on cardiac cells [61,73], especially on transport channels, whilst Ca2+, Mg2+, and Sr2+ appear to have less of an effect [73].
There have been informative reviews that broadly cover the topic of the effect of exposure to toxic metals on the cardiovascular system. For instance, there are reviews available for xenobiotic metals like lead [74,75], cadmium [74,75,76,77], mercury [49,74,75], and essential but toxic copper [75,78]. However, the direct effect of these ubiquitous chemicals on the cardiovascular system has not been extensively covered in reviews and is usually described in experimental articles. Furthermore, there are no comprehensive reviews and only limited information regarding the direct effect of these divalent cations on cardiac or skeletal muscle proteins.

2.2. Competition of Divalent Cations in the Body

Toxic cations such as cadmium, lead, and mercury can compete with other physiologically relevant divalent cations for entry into cells and in various biochemical reactions in the body. For example, cadmium absorption and accumulation may increase with zinc deficiency as cadmium can replace zinc in biochemical reactions [79,80,81,82,83]. Cadmium is also known to develop toxicity by competing with essential metal cations including calcium [42,84], iron, copper, and manganese for entry pathways [85]. Toxic cations can also deplete other important nutrients in the body, such as cadmium’s ability to deplete selenium, which is a crucial antioxidant and cofactor for various enzymes [86]. On the other hand, selenium is found to diminish cadmium cardiotoxicity [87]. Molecules specialized in the handling of alkaline earth (e.g., Mg2+, Ca2+) and transition metal ions (e.g., Zn2+, Cu2+, Fe2+) may be particularly sensitive to the presence of Cd2+ because they enclose cationic sites to which the toxic metal can bind [88].
Pb2+ can substitute calcium in calcium-binding proteins critical for heart function due to its similarity to Ca2+ [40,89,90,91]. Similarly, Pb2+ can replace other divalent metals such as zinc in zinc-finger proteins [92,93]. Lead can potentially lead to magnesium deficiency by inhibiting its absorption, which, in turn, may aggravate the negative effects of lead on the human body [94].
Both lead and mercury are powerful oxidizing agents in their +2 cationic state, with the ability to interfere significantly with processes that require specific divalent cations [40]. For example, mercury can interfere with Mg2+-binding sites because of their similar enthalpy energy dehydration values [40]. Interestingly, both toxic mercury and cadmium could have a competitive relationship in the accumulation in the myocardium [16].
Overall, competition between cations in the body is a vast topic that encompasses a range of divalent and trivalent ions that can compete for metal-binding structures in various tissues. For instance, Zn2+, Cu2+, Cd2+, and Hg2+ could compete for metal-binding sites of cardiac submitochondrial fragments [95]. Calcium can be replaced by strontium in various intracellular processes due to their high level of similarity [96]. Trivalent ions, e.g., Al3+ could also compete with Mn2+ and Mg2+ for binding sites due to their similarly small size [97,98,99].
In summary, understanding the competition between divalent and trivalent cations in the body is crucial for identifying potential strategies for preventing or treating cation-induced toxicity. Herewith, it is important to focus on their potential targets in the myocardium, as the known competition of two specific divalent cations in other tissues may be impossible in myocardium due to the absence of ways of entering for one or both cations in cardiac cells.

2.3. Entry Pathways for Divalent Cations into Cardiomyocytes

Various divalent cations interact with specific parts of the channels to affect their function [73]. Essential cations like calcium, magnesium, zinc, copper, etc. usually have their specific transporters or ion channels to enter cardiomyocytes [100]. For example, Mg2+ primarily enters cardiomyocytes through MgtE (SLC41A1) [101] and ACDP2 [102], and to a lesser extent through SLC41A2 [103], MMgT1, and MMgT2 [104].
Non-essential cations such as cadmium, lead, and mercury do not have specific ion channels or transport proteins on the cell membrane. Instead, they can utilize existing transport pathways to enter the cells [40,100]. For example, P1B-ATPases, which are transporters for cations via the membrane, are involved in the transport of Mn2+, Co2+, Cu2+, Ag+, Zn2+, Cd2+, Hg2+, and Pb2+, and may also play a role in Fe2+ and Ni2+ transport [105,106]. On the other hand, toxic metals like Pb, Cd, and Hg can enter tissues through multiple mechanisms due to ionic mimicry [107].
Cadmium has no specific ion channels or transport proteins on the cell membrane, and utilizes the transport pathways for calcium, zinc, iron, copper, and magnesium [60]. Cd2+ can enter cardiomyocytes through voltage-dependent Ca2+ channels [59,60,86], and inhibit or block the L-type Ca channel current in rabbit [108] and rat [109] ventricular myocytes. Detailed reviews devoted to cadmium entry through Ca2+ channels, transporters, receptors [85], and multiple sarcolemmal pathways, including Zn transporters [110], were published recently.
Lead ions can enter cardiomyocytes through various mechanisms, including Cav1.2 calcium channels [40], zinc transporters, anion exchangers, and non-voltage-dependent pathways [40]. Interestingly, currents through the Cav1.2 channels are smaller in the presence of Pb2+, but they last longer compared to those carried only by Ca2+ [40,63], similar to what has been described for inactivation by Ba2+ [111]. Moreover, Pb2+ can enter the cell through Trp channels with Ca2+-permeant pores that are known to be secondary entry pathways for divalent cations, in addition to other transport proteins like the Na+—Ca2+ exchanger, SOC channels, Zn2+ and other divalent metal transporters, pH-sensitive transporters, and aquaporin channels [40]. For details, see the review devoted to lead and mercury effects on voltage-gated calcium channel functioning [112].
Mercury ions can enter cells through various mechanisms, including ABC-type transporters and amino acid transporters and organic anion transporters. Since Hg2+ has a large ionic radius, it is unlikely that it enters the cardiomyocytes through Cav1.2 channels and it is more likely that it just blocks them. Although mercury may not enter through Cav1.2 channels [40], it potentially can enter cardiomyocytes through several pathways, including calcium transporters. Additionally, mercury ions can also enter cells via transporters for other divalent cations such as Zn2+ and Cu2+. It is worth noting that inorganic mercury has a low lipophilicity and thus has a limited ability to cross cell membranes [113].
For other non-essential cations, it is also possible to enter the cells. For example, nickel can enter cells through divalent metal transporters and inhibit mitochondrial function, leading to oxidative stress and DNA damage [100]. Cobalt can enter cells through calcium channels and disrupt mitochondrial function, leading to oxidative stress and apoptosis; cobalt excess can also cause severe cardiomyopathy [114,115]. The cardiac ryanodine receptor provides a suitable pathway for the rapid transport of Zn2+ [116], and the sarcoplasmic reticulum in cardiac muscle is suggested to act as a dynamic storage for Zn2+ release and reuptake [116]. Cobalt is a harmful cation that can infiltrate cells via calcium channels and interfere with mitochondrial function. This can result in oxidative stress and apoptosis, ultimately leading to severe cardiomyopathy.
Non-essential and non-native essential cations can use multiple transport processes to enter various cells. Most of these transport pathways have been confirmed to allow various cations to enter cardiomyocytes (Figure 1). For example, L-type calcium channels are a suitable entryway for Sr2+ [96], Fe2+ [117], Ni2+ [100], Cd2+ [118], and Pb2+ [40]; T-type calcium channels are suitable for Fe2+ [117] and Cd2+ [118]; store-operated channels (SOC) for Pb2+ [40]; transient receptor potential (TRP) channels for Fe2+ [117] and Pb2+ [40]; Piezo type mechanosensitive ion channel component 1 (Piezo1) for Hg2+ [119]; sodium-calcium exchanger (NCX) for Sr2+ [96] and Pb2+ [40]. Aquaporins could be used by Pb2+ [40]; magnesium transporters E (MgtE) by Mn2+ [101]; zinc-regulated, iron-regulated transporter-like proteins (ZIP) by Mn2+ [120], Fe2+ [117], and Cd2+ [120]; divalent metal transporter 1 (DMT1) by Mn2+ [121], Zn2+ [121], Cu2+ [122], Cd2+ [123], Pb2+ [40], and Hg2+ [124].
Once inside the cell, divalent cations such as cadmium [59,107,125,126], lead [125,126], and mercury [49,64,107] ions can bind efficiently to sulfhydryl groups (-SH) of proteins. This interaction of cations with thiol and other groups is a crucial factor in understanding the toxic effects of these cations on the body. These toxic cations can target important sites such as the calcium- and magnesium-binding sites of troponin C, the ventricular and atrial myosin regulatory light chains, and the ATP-binding pocket of myosin, leading to disruptions in cellular processes and potentially harmful cardiac effects.

2.4. Toxic Effects of Different Concentrations of Divalent Cations in Cells

Numerous studies have confirmed the ability of heart tissue to accumulate various divalent cations (see Section 2.1). However, the fraction of accumulation of cations specifically in cardiomyocytes remains unclear, while the heart tissue is composed of different cell types, including cardiomyocytes, cardiac fibroblasts, smooth muscle cells, endothelial cells, etc. [127]. The range of concentrations of these cations in cardiomyocytes are unknown for most cations, and therefore the evaluation of the potential toxic effect connected with their concentrations is difficult.
It could be proposed that highly toxic xenobiotic cations such as Pb2+, Cd2+, and Hg2+ could have an adverse effect on the heart at any concentration within cardiomyocytes. For example, the addition of Pb up to 100 μM has been shown to have negative cardioinotropic effects on cardiomyocytes [63]. Similarly, the addition of 1 mM of Cd inhibited the time-dependent hyperpolarization-activated inward current on pulmonary vein and left atrial cardiomyocytes [128]. Heightened accumulation of mercury in the myocardium has been observed in idiopathic dilated cardiomyopathy (22-fold) and secondary forms of cardiac dysfunction (3-fold) patients [15].
While free Cu is absent inside cells [129], some essential divalent cations have a certain concentration in normal conditions. For example, intracellular rest Ca2+ is ~0.0001 mM/L and extracellular rest ~1.2 mM/L [130]. In toxic conditions, such as malignant hyperthermia, excessive calcium release from the sarcoplasmic reticulum leads to disturbances in intracellular Ca2+ homeostasis, uncontrolled skeletal muscle hypermetabolism, and arrhythmias [131,132]. The cytosolic free magnesium ion concentration is 0.85 ± 0.1 mM, but it can significantly increase to a level of 2.1 ± 0.4 mM under ischemia [133]. Another study has confirmed an increase in free intracellular Mg2+ concentrations under ischemia [134]. However, in the myocardial tissue of men with sudden death from myocardial infarction, the Mg2+ concentration is decreased [135].
To summarize, further research is needed to better understand the concentration range of various cations in cardiomyocytes, a topic which is still is largely unknown, which makes it challenging to assess their potential toxic effects.

3. EF-Hand Protein Family and Divalent Cations

The EF-hand family are calcium-binding proteins with a structural motif called the EF-hand, which participate in various cellular processes, including muscle contraction [136]. The EF-hand protein family has been studied extensively, and Snyder et al. [137] have concluded that the binding of metal ions to the EF-hand motif is dependent on their charge and size [137]. The EF-hand binding sites are specifically designed to bind highly charged cations, resulting in low affinities for monovalent metals such as Na+ and K+. Therefore, these metals are not included in our research focus, despite the fact that myocardium is known to accumulate various chemicals, including monovalent ones [27]. The size of the cavity of binding sites is optimized for divalent metals that have effective ionic radii similar to Ca2+, i.e., optimal binding occurs at an ionic radius between those of Mg2+ (0.81 A) and Ca2+ (1.06 A) [137]. Additionally, trivalent metal ions of the group IIIA and the lanthanides also exhibit size-dependent affinities, with an optimal effective ionic radius between those of Sc3+ (0.81 A) and Yb3+ (0.925 A) [137].
Calmodulin plays a crucial role in regulating myosin light chain kinase activity in smooth muscles and, being a member of the EF-hand family, has calcium-binding sites [138]. It has been shown that Ca2+ can be substituted by bi- and trivalent cations with similar ionic radii viz. Zn2+, Mn2+, Cd2+, Sr2+, Pb2+, Cr2+, Tb3+, Sm3+, and La+ [84,139], altering the conformation of calmodulin. Sr2+, Pb2+, Cd2+, and Cr2+ can stimulate the activity of calmodulin to varying degrees, from 60% to 90% [138,139]. Sr2+ is also known to bind to α-parvalbumin, which is another member of the EF-hand family [140]. On the other hand, Na+, Mg2+, Ba2+, and Ni2+ had no distinct effect on calmodulin [84]. Data on the affinity of Al3+ and Hg2+ to calmodulin are contradictory [84,139,141], though there is an opinion that Zn2+, Al3+, and Hg2+ do not affect calmodulin activity at concentrations up to 1 mM [139]. It is noteworthy that various cations may exhibit different degrees of affinity towards the distinct binding sites of calmodulin [39], with the lead having a higher affinity for calmodulin binding sites than other metals [142], especially in the N-terminal domain where Pb2+ binds with an 8-fold higher affinity than Ca2+ [90].
Concerning proteins affected by lead, de Souza et al. [142] described many such proteins and proposed that their number is probably much higher. This hypothesis could be proposed for proteins of the EF-hand family and other cations. Such ionic displacement (e.g., ionic mimicry) or opportunistic binding of cations to proteins [90], such as with the EF-hand family, could underlie the mechanisms of toxicity.

3.1. Troponin C

Troponin C is a subunit of cardiac and skeletal troponin and, like calmodulin, it is a member of the EF-hand family, which has calcium-binding sites [143]. In both skeletal and cardiac troponin C, there are Ca2+ binding sites, two of which are high-affinity sites, which can also bind other divalent cations such as Mg2+ and Cd2+ [143]. Troponin C also has low-affinity Ca2+-specific sites (2 sites for skeletal TnC and 1 site for cardiac TnC), which are highly selective to Ca2+ under a normal physiological concentration of Mg2+ [143]. Previous studies have shown that Ca2+ could be substituted by Cd2+ (72% of calcium ions were substituted), Sr2+ (57%), Pb2+ (45%), and Mn2+ (35%), Co2+ (12%), Ni2+ (10%), Ba2+ (10%), Mg2+ (8%), and Zn2+ (6%) ions with a concentration 0.1 mM. The affinity of divalent cations for the receptor site of troponin C is closely related to their ionic radius and its proximity to the ionic radius of Ca2+.
Trivalent lanthanide ions such as La3+, Ce3+, Nd3+, Sm3+, and Dy3+ can partially displace about 25–35% of the bound Ca2+ from troponin C at a concentration of 0.02 mM, but their affinity for the receptor site is lower than that of Ca2+ despite their similarity to Ca2+ in size and chemical properties. To compare, the same concentrations of Cd2+ and Sr2+ could displace 40 and 29% of the bound Ca2+, respectively [144]. Pb2+ and Cd2+ can bind to skeletal muscle troponin C and activate myosin ATPase activity at a low concentration, but significantly decrease ATPase activity at concentrations higher than 100 µM [42]. Interestingly, Sr2+ can activate the contractile process in diaphragm fibres, and the response is dependent on the composition of TnC isoforms, with the slow isoform conferring on average a 7-fold greater sensitivity to Sr2+ than the fast isoform [145].

3.2. Regulatory Light Chain

Cardiac myosin filaments are directly regulated by calcium ions, as reported by Ma et al. [146]. Currently, two substructures of myosin that are capable of binding calcium ions are confirmed: the ATP-binding pocket and the regulatory light chain (RLC). The myosin RLC belongs to the EF-hand family and contains the EF-hand domain responsible for binding calcium and magnesium cations [147]. Under relaxed conditions, the myosin RLC EF-hand domains have been observed to bind magnesium (Mg2+), but as the concentration of calcium ions increases during muscle contraction, they become increasingly occupied by Ca2+ [148]. At the same time, the elevated free Mg2+ concentration reduces the Ca2+ sensitivity of skeletal myosin and this effect could be associated with the influence of the RLC [149].
The function of cation-binding sites in muscle contraction is important, but not fully understood [148]. Optimal binding to the EF-hand occurs at an ionic radius close to Mg2+ and Ca2+. However, the affinity of the EF-hand-like Ca2+ binding sites [97,150], including those of smooth muscle RLC [151], to cations can be significantly altered by amino acid substitutions. For instance, Da Silva et al. [151] demonstrated that amino acid substitutions could alter the affinity of the EF-hand in smooth muscle RLC to divalent ions (Mg2+ or Ca2+). This effect may be important in mutations that cause alterations in the amino acid sequence. Moreover, post-translational modification hypothetically could influence the affinity of proteins to divalent cations. For α-synuclein, it has been shown that phosphorylation in very close proximity to the putative metal binding sites, could increase the binding affinity of Cu(II), Pb(II), and Fe(II) [152]. However, it remains unclear whether this is also true for EF-hand proteins.
It is highly possible that various cations, including toxic Pb2+, Cd2+, and Hg2+, may compete with Ca2+ not only for the calcium-binding sites of calmodulin [138] and skeletal troponin C [42] as described above, but also for other members of the EF-hand family, such as cardiac troponin C and atrial and ventricular myosin regulatory light chains.

4. The Myosin ATP-Binding Pocket

The myosin ATP-binding pocket binds both ATP and Mg2+ (MgATP) to coordinate ATP hydrolysis for force generation and muscle contraction [153]. While MgATP is the natural substrate [154], myosin is not a specific ATPase, and the myosin ATP-binding pocket can bind other divalent cations, such as Ca2+ [153,154,155], and Mn2+ [153], which support myosin ATPase activity (Table 1).
The concentration of CaATP in the sarcomere reaches 64–71 μM [156], which is about 1% of all available ATP [155]. The rate of the basal CaATPase activity is higher than that of MgATPase [153,154,155,157], and actin-activated CaATPase activity is also higher than that of MgATPase [155,157], or does not have a significant difference [153,154]. The rate of ATP binding is higher in the presence of Ca2+ than in the presence of Mg2+ [155], and at the same time, CaATP dissociates actomyosin 3–4 times slower than MgATP [154,155,157], increasing the time of strong actomyosin binding. The authors pointed out a higher actin affinity when S1-CaADP- Pi is converted to S1-CaADP, compared to the magnesium case [154], and that CaATP binds tighter to myosin than MgATP [155]. It was shown that the isometric force produced by muscle fibres when CaATP was the substrate is only 20% of the value obtained with MgATP [154]. Later, it was proposed that myosin readily produces futile strokes with CaATP [155]. At the same time, the gliding assay indicated that myosin did not propel F-actin in the presence of Ca2+ ions [153]. In healthy muscles, contraction occurs regardless of the small amount of CaATP that is always present in the muscle [155,156]. However, Ge et al., proposed that an increase of Ca2+ during disturbed calcium homeostasis in the muscle will increase the probability of finding CaATP [155].
In the presence of physiologically essential Mn2+, the rate of basal [153,157,158] and actin-activated [153,159,160] MnATPase activity is higher than that of MgATPase. However, there was no statistically significant F-actin stimulation for MnATPase [153], and no alteration in the mechanical characteristics of skeletal fibres [160]. In the presence of Mn2+, the sliding velocity of F-actin over myosin was inhibited approximately 3-fold compared to Mg2+ [153]. The rate of movement of the myosin lever arm and phosphate release in MnATPase cycles are significantly accelerated compared to the MgATPase cycle [157]. Walker et al. concluded that a significant proportion of myosin might undergo the power stroke and phosphate release before reattaching to the F-actin filament. As a result, there is an increase in the probability of futile power strokes that could explain the reduced motility observed for myosin in the presence of Mn2+ compared to Mg2+ [153].
If essential cations can significantly influence the ATPase activity, xenobiotics with a high degree of probability may have a similar effect. For instance, acute lead exposure could influence myocardial contractility through alterations in the ATPase activity of myosin [62]. Specifically, exposure to 8 μM lead acetate was shown to increase the ATPase activity of left-ventricular myosin by 30% [161]. However, exposure to 100 μM lead acetate has been shown to reduce ATPase activity of right-ventricular myosin by 26% [62]. This contradiction could be a result of different doses of lead or different ventricles from which the myosin was extracted. The first assumption is more possible, as myosin of both ventricles have the same structure, and may differ only in the ratio of myosin heavy chain isoforms [162]. Chao et al. have shown that myofibrillar PbATPase activity in the presence of TnC was higher than that of CaATPase at a concentration of ca. 100 µM and decreased at higher concentrations. Without TnC, myofibrillar PbATPase was comparable to that of CaATPase at concentrations lower than 75 µM and decreased at higher concentrations [42].
Similar results were shown for cadmium: myofibrillar CdATPase activity in the presence of TnC was lower than that of CaATPase. Without TnC, myofibrillar PbATPase was comparable to that of CaATPase at concentrations lower than 75 µM and increased at higher concentrations [42].
Extracellular Hg2+ significantly reduces the contraction of isolated guinea-pig cardiomyocytes [40] and inhibits myosin ATPase activity. Myosin ATPase activity was shown to be completely blocked with 1 μM Hg2+ and reduced by 50% with 0.15 μM Hg2+ [65]. Later, similar results were shown, i.e., HgCl2 reduced the activity of myosin ATPase in a dose-dependent manner, beginning from small concentrations of 50 nM, and achieved about a 45% reduction in activity following exposure to 100 nM HgCl2 [64].
Many other divalent cations are also able to support myosin ATPase activity in experimental conditions. For instance, Fe2+, Mn2+, Ni2+, and Co2+ support the ATPase activity of S1-myosin in the absence of actin, and this activity increases with the increasing ionic radius of the metal (Me) ions [159]. These metal ions also support actin activation; however, there is no strong correlation between actin-activated MeATPase activity and their ionic radii [159]. At the same time, NiATP does not support muscle fibre contraction [160]. Zn2+ [163] and Cu2+ [67] significantly inhibit ATPase activity, while Al has no effect [163]. Wherein, Sr2+ has been found to activate actomyosin ATPase and has often been used as a Ca2+ surrogate to regulate muscle contraction in experimental conditions [4].
In a normal actin-myosin interaction, Mg2+ stimulates myosin ATPase activity. However, other divalent cations can significantly affect the kinetics of myosin. The specific cation appears to play a critical role in this effect. Physiologically relevant cations (Ca2+, Mn2+) could intervene in the ATPase activity, and low concentrations of the toxic and xenobiotic metals, e.g., Pb2+, Hg2+, Cd2+ inhibit the activity of myosin ATPase, suggesting a strong toxic effect. Previous studies have shown a linear relationship between the ionic radius of Ca2+, Mg2+, and Mn2+ and the respective basal and actin-activated ATPase activities in the presence of these cations [157]. The larger the ionic radius, the higher the myosin ATPase activity. However, it should be checked for more cations, which are shown to have myosin ATPase activity e.g., Pb, Cd, Hg etc. Interestingly, actin activation of myosin ATPase does not depend on the metal cation, despite the cation-specific kinetics of nucleotide binding and dissociation. The rate-limiting step of myosin ATPase activity depends on the metal cation, with the rate of the recovery stroke and reverse recovery stroke being directly proportional to the ionic radius of the cation. The rate of nucleotide release from myosin and actomyosin and ATP binding to actomyosin depends on the cation coordination number [157].
Table 1. Influence of divalent cations on myosin ATPase activity.
Table 1. Influence of divalent cations on myosin ATPase activity.
CationCompoundConcentrationChange of Basal ATPase Activity, % *Change of Actin-Activated ATPase Activity, % *Velocity in Motility (Gliding) Assay, % *ObjectReference
CaCaCl21 µM−10 Rabbit fast skeletal muscle myofibrilsChao, 1990 [42]
10 µM+305
50 µM+350
100 µM+350
1 mM+328
1 mM+655−52 Rabbit fast skeletal muscle myosin S1 fragmentPeyser, 1996 [159]
2 mM No motilityDictyostelium discoideum myosin IIWalker, 2021 [153]
5 mM+1450+475
+4333+516 Rabbit fast skeletal muscle myosinGe, 2019 [155]
+3544−16 Polosukhina, 2000 [154]
MnMnCl21 mM+383+12 Myosin S1 fragment back and leg muscles of rabbitPeyser, 1996 [159]
2 mM −63Dictyostelium discoideum myosin IIWalker, 2021 [153]
5 mM+4900+1050 Dictyostelium discoideum myosin IIWalker, 2021 [153]
6 mM +32 Rabbit fast skeletal muscle myosin S1 fragmentBurton, 2005 [160]
PbPb(C2H3O2)28 µM+30 Rat left ventricle myosinFioresi, 2013 [161]
100 µM−26 Rat right ventricle myosinVassallo, 2008 [62]
PbCl21 µM−1 Rabbit fast skeletal muscle myofibrilsChao, 1990 [42]
10 µM+215
50 µM+395
100 µM+373
1 mM+58
CdCdCl21 µM−15 Rabbit fast skeletal muscle myofibrilsChao, 1990 [42]
10 µM+170
50 µM+340
100 µM+305
1 mMNo activity
HgHgCl250 nM−20 Rat left ventricle myosinMoreira, 2003 [64]
100 nM−40
150 nM−50 Vassalo, 1999 [65]
200 nM−55 Moreira, 2003 [64]
300 nM−70
400 nM−80
CuCuCl210 μg/mL−67 Rat left ventricle myosinFiletti, 2018 [67]
NiNiCl21 mM−43−76 Rabbit fast skeletal muscle myosin S1 fragmentPeyser, 1996 [159]
Ni(CH3CO2)25 mM −63 Rabbit fast skeletal muscle myosin S1 fragmentBurton, 2005 [160]
ZnZnSO4100 µM−40 Rabbit fast skeletal muscle myosinJones, 1997 [163]
250 µM−75
500 µM−85
1 mM−90
AlAlCl3100 µMNo effect Rabbit fast skeletal muscle myosinJones, 1997 [163]
250 µM+10
500 µM+10
1 mMNo effect
AlC6H5O100 µMNo effect Rabbit fast skeletal muscle myosinJones, 1997 [163]
250 µMNo effect
500 µMNo effect
1 mMNo effect
FeFeCl21 mM+360−45 Rabbit fast skeletal muscle myosin S1 fragmentPeyser, 1996 [159]
CoCoCl21 mM+262−27 Rabbit fast skeletal muscle myosin S1 fragmentPeyser, 1996 [159]
* Percentage change of described ATPase compared to native or experimental MgATPase activity.
It is worth noting that divalent cations have been shown to influence the ATPase activity of various motor proteins, including kinesin [164], non-muscle [165], and muscle [154,155] myosin. Walker et al. pointed out that in kinesin, microtubule gliding velocities, as well as basal and microtubule-stimulated ATPase rates, were similar with either Mn2+ or Mg2+ [164], unlike in myosin where the basal ATPase activity was stimulated by MnATP but not by MgATP [165]. Apparently, different motor proteins and isoforms of myosin may respond differently to the same cations due to differences in their structure. Therefore, it is essential to investigate how various cations can affect different motor proteins. Moreover, it is important to consider the possibility that ATPase activity may be influenced not only by cation interactions with the myosin ATP-binding pocket but also by metal binding to the RLC or other unknown mechanisms. Further investigation is necessary to fully understand the impact of metal binding on the RLC and its potential effect on ATPase activity.

5. Materials and Methods

This review was prepared following the PRISMA statement guidelines [166]. Using databases MEDLINE (via PubMed) and Google Scholar, we searched for articles that met specific criteria:
(1)
In the article title, at least one of the following words was found: “heart OR cardiomyocytes OR cardiotoxicity OR myocardial OR cardiac OR cardiovascular OR cardiomyopathy”.
(2)
In the found article, the chemical symbol, English, or Latin name of the divalent cation must be present in the article body. Namely [167], beryllium (Be2+), magnesium (Mg2+), calcium (Ca2+), strontium (Sr2+), barium (Ba2+), radium (Ra2+), vanadium (Va2+), chromium (Cr2+), manganese (Mn2+), iron/ferrum (Fe2+), ruthenium (Ru2+), osmium (Os2+), cobalt (Co2+), rhodium (Rh2+), nickel (Ni2+), palladium (Pd2+), platinum (Pt2+), copper/cuprum (Cu2+), zinc (Zn2+), cadmium (Cd2+), mercury (Hg2+), tin/stannum (Sn2+), lead/plumbum (Pb2+), polonium (Po2+). Divalent lanthanides that are known in the solid state but are unstable in water: neodymium (Nd2+), samarium (Sm2+), europium (Eu2+), dysprosium (Dy2+), Thulium (Tm2+), ytterbium (Yb2+). Divalent actinides (all artificially made): americium (Am2+), californium (Cf2+), einsteinium (Es2+), fermium (Fm2+), mendelevium (Md2+), nobelium (No2+).
(3)
In the found article, at least one of the words must be present in the text “transport”, “channel”, “accumulation”, “cardiotoxicity”, or “intoxication”. Additional search and selection were also made on the exact phrase according to the template “divalent cation + key word”, e.g., “copper cardiotoxicity”. All publications were screened based on their title and abstract to assess their relevance and eligibility, with special attention given to the known or proposed influence of divalent cations on the contractile or regulatory muscle proteins. More than 170 papers were carefully read and processed, and ca. 135 articles devoted to cations were utilized for the manuscript draft, which was revised several times.
The curation of text was conducted by dint of Artificial Intelligence (AI) Language Model ChatGPT 3.5 using an enquiry “AI, improve the following text with special attention to English grammar, punctuation, and grammatical form of time”. The AI made minor improvements to the text, but the authors retained discretion over word choice and final correction. The total time spent working on the manuscript took more than 8000 min, excluding the search, selection, and reading of articles. After revisions, a final version of the manuscript was prepared and approved by all the authors.

6. Conclusions

Heart contraction is a highly coordinated process that involves the interplay of multiple molecules, including calcium- and magnesium-binding protein structures. Essential and xenobiotic divalent cations can accumulate in the myocardium, enter cardiac cells, and possibly bind to proteins, altering their functions.
The EF-hand family proteins have binding sites optimized for highly charged cations that have effective ionic radii close to that of Mg2+ and Ca2+. However, only a few members of the EF-hand family viz. calmodulin, α-parvalbumin, skeletal troponin C, and smooth muscle RLC were investigated concerning their ability to bind various divalent cations.
Calmodulin alters its conformation when at binding sites where Ca2+ has been substituted by bi- or trivalent cations with similar ionic radii viz. Cd2+, Sr2+, Pb2+, Cr2+, Zn2+, Mn2+, Tb3+, Sm3+, and La+. Data on the affinity of Al3+ and Hg2+ to calmodulin are contradictory. Cd2+, Sr2+, Pb2+, Cr2+ stimulate the calmodulin activity to varying degrees. Zn2+, Al3+, and Hg2+ do not affect calmodulin activity at concentrations up to 1 mM. Na+, Mg2+, Ba2+, and Ni2+ had no distinct effect on calmodulin. α-parvalbumin, which is a canonical calcium-binding protein, was shown to bind Sr2+. In skeletal Troponin C, Cd2+, Sr2+, Pb2+, Mn2+, Co2+, Ni2+, Ba2+, Mg2+, Zn2+, and trivalent lanthanides such as La3+, Ce3+, Nd3+, Sm3+, and Dy3+ can substitute for Ca2+. Smooth muscle RLC was shown to significantly alter affinity to divalent cations, i.e., Ca2+ and Mg2+, after amino acid substitutions.
Thus, various cations, including essential Zn2+, Cu2+, etc., and toxic Pb2+, Cd2+, and Hg2+, may compete with Ca2+ for the calcium-binding sites of EF-hand proteins, altering their functions. Therefore, it is necessary to study whether cardiac troponin C and atrial and ventricular myosin regulatory light chains could be potential targets for these cations.
As myosin ATPase is not specific, many cations, including Ca2+, Fe2+, Mn2+, Ni2+, Sr2+, and Co2+, could support its ATPase activity. At the same time, some other cations such as Zn2+ and Cu2 significantly inhibit ATPase activity. Therefore, further investigation is necessary to fully understand the possibility of cations binding by a myosin ATP-binding pocket. It is important to consider the possibility that ATPase activity may be influenced not only by cation interactions with the myosin ATP-binding pocket but also by metal binding to the RLC.
The main question is whether cations could influence myosin and troponin kinetics in real conditions. In healthy muscles, contraction occurs regardless of the small amount of e.g., CaATP that is always present in the muscle. However, in certain disturbances of cation homeostasis, concentration of physiologically relevant divalent ions can be increased, significantly affecting the kinetics of the interaction between myosin and actomyosin. For instance, Ca2+ can be increased and CaATPase activity may contribute to observed muscle rigidity and enhanced muscle thermogenesis as in malignant hyperthermia, or Cu2+ can significantly increase in Wilson disease [168], with uninvestigated possible effects. The potential effect apparently depends on the ionic radius and charge of the specific cation, its concentration in the cell, and the specific isoform of protein. In addition, the affinity of EF-hand-like Ca2+ binding sites or other targets for divalent ions may be significantly altered by amino acid substitutions or post-translational modification.
Further investigation is necessary to fully understand the mechanisms of cation entry into cells, their competition, possible targets, affinity to these targets in different cation concentrations, and their influence on the mechanical characteristics of cardiac contractile and regulatory proteins. It is important to thoroughly study both essential and xenobiotic cations, with a priority on toxic cations, while not omitting trivalent cations. We hope that our review will help to provide direction for further investigations.

Author Contributions

Conceptualization, O.P.G. and L.V.N.; methodology, V.O.V., A.E.T. and I.K.P.; validation, O.P.G.; writing—original draft preparation, O.P.G., V.O.V. and I.K.P.; writing—review and editing, O.P.G., A.E.T. and L.V.N.; supervision, L.V.N.; project administration, L.V.N.; funding acquisition, O.P.G. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by RSF, grant number 22-74-00128.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

No new data were created or analyzed in this study.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Huxley, H.E. The Mechanism of Muscular Contraction. Sci. Am. 1965, 213, 18–27. [Google Scholar] [CrossRef] [Green Version]
  2. Weeds, A.G.; Lowey, S. Substructure of the Myosin Molecule. II. The Light Chains of Myosin. J. Mol. Biol. 1971, 61, 701–725. [Google Scholar] [CrossRef] [PubMed]
  3. Ebashi, S.; Endo, M.; Ohtsuki, I. Control of Muscle Contraction. Q. Rev. Biophys. 1969, 2, 351–384. [Google Scholar] [CrossRef] [PubMed]
  4. Ebashi, S.; Endo, M. Calcium and Muscle Contraction. Prog. Biophys. Mol. Biol. 1968, 18, 123–183. [Google Scholar] [CrossRef] [PubMed]
  5. Gordon, A.M.; Homsher, E.; Regnier, M. Regulation of Contraction in Striated Muscle. Physiol. Rev. 2000, 80, 853–924. [Google Scholar] [CrossRef]
  6. Lymn, R.W.; Taylor, E.W. Mechanism of Adenosine Triphosphate Hydrolysis by Actomyosin. Biochemistry 1971, 10, 4617–4624. [Google Scholar] [CrossRef]
  7. Onishi, H.; Mochizuki, N.; Morales, M.F. On the Myosin Catalysis of ATP Hydrolysis. Biochemistry 2004, 43, 3757–3763. [Google Scholar] [CrossRef]
  8. Kawasaki, Y.; van Eerd, J.-P. Biochemical and biophysical research communications. Biochem. Biophys. Res. Commun. 1972, 46, 335–340. [Google Scholar]
  9. Alexis, M.N.; Gratzer, W.B. Interaction of Skeletal Myosin Light Chains with Calcium Ions. Biochemistry 1978, 17, 2319–2325. [Google Scholar] [CrossRef]
  10. Kintses, B.; Gyimesi, M.; Pearson, D.S.; Geeves, M.A.; Zeng, W.; Bagshaw, C.R.; Málnási-Csizmadia, A. Reversible Movement of Switch 1 Loop of Myosin Determines Actin Interaction. EMBO J. 2007, 26, 265–274. [Google Scholar] [CrossRef]
  11. Webb, J.; Kirk, K.A.; Niedermeier, W.; Griggs, J.H.; Turner, M.E.; James, T.N. Distribution of 13 Trace Metals in Pig Heart Tissue. Bioinorg. Chem. 1973, 3, 61–75. [Google Scholar] [CrossRef]
  12. Novaes, R.D.; Mouro, V.G.S.; Gonçalves, R.V.; Mendonça, A.A.S.; Santos, E.C.; Fialho, M.C.Q.; Machado-Neves, M. Aluminum: A Potentially Toxic Metal with Dose-Dependent Effects on Cardiac Bioaccumulation, Mineral Distribution, DNA Oxidation and Microstructural Remodeling. Environ. Pollut. 2018, 242, 814–826. [Google Scholar] [CrossRef] [PubMed]
  13. Park, E.J.; Lee, G.H.; Yoon, C.; Jeong, U.; Kim, Y.; Cho, M.H.; Kim, D.W. Biodistribution and Toxicity of Spherical Aluminum Oxide Nanoparticles. J. Appl. Toxicol. 2016, 36, 424–433. [Google Scholar] [CrossRef] [Green Version]
  14. Zhou, L.F.; He, M.; Li, X.L.; Lin, E.; Wang, Y.C.; Wei, H.; Wei, X. Molecular Mechanism of Aluminum-Induced Oxidative Damage and Apoptosis in Rat Cardiomyocytes. Biol. Trace Elem. Res. 2022, 200, 308–317. [Google Scholar] [CrossRef] [PubMed]
  15. Frustaci, A.; Magnavita, N.; Chimenti, C.; Caldarulo, M.; Sabbioni, E.; Pietra, R.; Cellini, C.; Possati, G.F.; Maseri, A. Marked Elevation of Myocardial Trace Elements in Idiopathic Dilated Cardiomyopathy Compared with Secondary Cardiac Dysfunction. J. Am. Coll. Cardiol. 1999, 33, 1578–1583. [Google Scholar] [CrossRef] [Green Version]
  16. Ali, S.; Awan, Z.; Mumtaz, S.; Shakir, H.A.; Ahmad, F.; Ulhaq, M.; Tahir, H.M.; Awan, M.S.; Sharif, S.; Irfan, M.; et al. Cardiac Toxicity of Heavy Metals (Cadmium and Mercury) and Pharmacological Intervention by Vitamin C in Rabbits. Environ. Sci. Pollut. Res. 2020, 27, 29266–29279. [Google Scholar] [CrossRef]
  17. Thind, S. Cadmium Und Zinc Distribution in Cardiovascular of Normal and Cadmium-Treated and Other Dogs L. Exp. Mol. Pathol. 1975, 22, 326–334. [Google Scholar] [CrossRef]
  18. Ashraf, W. Accumulation of Heavy Metals in Kidney and Heart Tissues of Epinephelus Micrdon Fish from the Arabian Gulf. Environ. Monit. Assess. 2005, 101, 311–316. [Google Scholar] [CrossRef]
  19. Kopp, S.J.; Perry, H.M.; Glonek, T. Cardiac Physiologic-Metabolic Changes after Chronic Low-Level Heavy Metal Feeding. Am. J. Physiol. Heart Circ. Physiol. 1980, 8, 22–30. [Google Scholar] [CrossRef]
  20. Nefedova, E.A.; Halperin, A.I.; Shatornaya, V.F.; Shevchenko, I.V.; Demidenko, Y.V.; Pridius, I.A.; Myasoyed, Y.P. Experimental Determination of the Accumulation of Cadmium Salts in the Heart of the Embryo of Rat and Their Effect on Rat Cardiogenesis. Theor. Med. 2020, 1, 91–110. [Google Scholar] [CrossRef]
  21. Yazihan, N.; Koçak, M.K.; Akçil, E.; Erdem, O.; Sayal, A.; Güven, C.; Akyürek, N. Involvement of Galectin-3 in Cadmium-Induced Cardiac Toxicity. Anadolu Kardiyol. Derg. 2011, 11, 479–484. [Google Scholar] [CrossRef] [Green Version]
  22. Speich, M. Concentrations of Lead, Cadmium, and Zinc in Human Heart Muscle and Aorta after Acute Myocardial Infarction. J. Am. Coll. Nutr. 2013, 1, 255–262. [Google Scholar] [CrossRef] [PubMed]
  23. Jamall, I.S.; Naik, M.; Sprowls, J.J.; Trombetta, L.D. A Comparison of the Effects of Dietary Cadmium on Heart and Kidney Antioxidant Enzymes: Evidence for the Greater Vulnerability of the Heart to Cadmium Toxicity. J. Appl. Toxicol. 1989, 9, 339–345. [Google Scholar] [CrossRef]
  24. Liang, Y.; Young, J.L.; Kong, M.; Tong, Y.; Qian, Y.; Freedman, J.H.; Cai, L. Gender Differences in Cardiac Remodeling Induced by a High-Fat Diet and Lifelong, Low-Dose Cadmium Exposure. Chem. Res. Toxicol. 2019, 32, 1070–1081. [Google Scholar] [CrossRef] [PubMed]
  25. Iwao, S.; Tsuchiya, K.; Sugita, M. Variation of Cadmium Accumulation among Japanese. Arch. Environ. Health 1983, 38, 156–162. [Google Scholar] [CrossRef]
  26. Lin, H.; Tai, Y.; Chou, S.; Cheng, C.; Ho, C.; Lin, H. The Preferential Accumulation of Cadmium Ions among Various Tissues in Mice The Preferential Accumulation of Cadmium Ions among Various Tissues in Mice. Toxicol. Rep. 2022, 9, 111–119. [Google Scholar] [CrossRef]
  27. Kliver, E.E.; Okuneva, G.N.; Levicheva, E.N.; Nepomnyashchikh, L.M.; Loginova, I.Y.; Volkov, A.M.; Lushnikova, E.L.; Trunova, V.A.; Zvereva, V.V. Anatomical Variants of Transposition of the Main Vessels and Their Relationship with the Content of Chemical Elements in Heart Ventricles. Bull. Exp. Biol. Med. 2008, 145, 638–641. [Google Scholar] [CrossRef]
  28. Frank, A.; Wibom, R.; Danielsson, R. Myocardial Cytochrome c Oxidase Activity in Swedish Moose (Alces alces L.) Affected by Molybdenosis. Sci. Total Environ. 2002, 290, 121–129. [Google Scholar] [CrossRef]
  29. Crawford, A.J.; Bhattacharya, S.K. Excessive Intracellular Zinc Accumulation in Cardiac and Skeletal Muscles of Dystrophic Hamsters. Exp. Neurol. 1987, 95, 265–276. [Google Scholar] [CrossRef]
  30. Kaduk, B.; Metze, K.; Schmidt, P.F.; Brandt, G. Secondary Athrocytotic Cardiomyopathy—Heart Damage Due to Wilson’s Disease. Virchows Arch. A Pathol. Anat. Histol. 1980, 387, 67–80. [Google Scholar] [CrossRef]
  31. Pan, M.; Cheng, Z.; Huang, C.; Ye, Z.; Sun, L.; Chen, H.; Fu, B.; Zhou, K.; Fang, Z.; Wang, Z.; et al. Long-Term Exposure to Copper Induces Mitochondria-Mediated Apoptosis in Mouse Hearts. Ecotoxicol. Environ. Saf. 2022, 234, 113329. [Google Scholar] [CrossRef]
  32. Gilmour, P.S.; Schladweiler, M.C.; Nyska, A.; McGee, J.K.; Thomas, R.; Jaskot, R.H.; Schmid, J.; Kodavanti, U.P. Systemic Imbalance of Essential Metals and Cardiac Gene Expression in Rats Following Acute Pulmonary Zinc Exposure. J. Toxicol. Environ. Health Part A Curr. Issues 2006, 69, 2011–2032. [Google Scholar] [CrossRef]
  33. Schroeder, H.A.; Mitchener, M.; Nason, A.P. Life Term Effects of Nickel in Rats: Survival, Tumors, Interactions with Trace Elements and Tissue Levels. J. Nutr. 1974, 104, 239–243. [Google Scholar] [CrossRef]
  34. Whanger, P.D. Effects of Dietary Nickel on Enzyme Activities and Mineral Contents in Rats. Toxicol. Appl. Pharmacol. 1973, 25, 323–331. [Google Scholar] [CrossRef] [PubMed]
  35. Davuljigari, C.B.; Gottipolu, R.R. Late-Life Cardiac Injury in Rats Following Early Life Exposure to Lead: Reversal Effect of Nutrient Metal Mixture. Cardiovasc. Toxicol. 2020, 20, 249–260. [Google Scholar] [CrossRef] [PubMed]
  36. Brurok, H.; Schjøtt, J.; Berg, K.; Karlsson, J.O.G.; Jynge, P. Manganese and the Heart: Acute Cardiodepression and Myocardial Accumulation of Manganese. Acta Physiol. Scand. 1997, 159, 33–40. [Google Scholar] [CrossRef] [PubMed]
  37. Novelli, E.L.B.; Rodrigues, N.L.; Sforcin, J.M.; Ribas, B.O. Toxic Effects of Nickel Exposure on Heart and Liver of Rats. Toxic Subst. Mech. 1997, 16, 251–258. [Google Scholar] [CrossRef]
  38. Ilbäck, N.G.; Fohlman, J.; Friman, G. A Common Viral Infection Can Change Nickel Target Organ Distribution. Toxicol. Appl. Pharmacol. 1992, 114, 166–170. [Google Scholar] [CrossRef]
  39. Ouyang, H.; Vogel, H.J. Metal Ion Binding to Calmodulin: NMR and Fluorescence Studies. BioMetals 1998, 11, 213–222. [Google Scholar] [CrossRef]
  40. Ferreira, G.; Santander, A.; Chavarría, L.; Cardozo, R.; Savio, F.; Sobrevia, L.; Nicolson, G.L. Functional Consequences of Lead and Mercury Exposomes in the Heart. Mol. Aspects Med. 2022, 87, 101048. [Google Scholar] [CrossRef]
  41. Barceloux, D.G. Molybdenum. Clin. Toxicol. 1999, 37, 231–237. [Google Scholar] [CrossRef] [PubMed]
  42. Chao, S.H.; Bu, C.H.; Cheung, W.Y. Activation of Troponin C by Cd2+ and Pb2+. Arch. Toxicol. 1990, 64, 490–496. [Google Scholar] [CrossRef] [PubMed]
  43. Nakayama, S.F.; Iwai-Shimada, M.; Oguri, T.; Isobe, T.; Takeuchi, A.; Kobayashi, Y.; Michikawa, T.; Yamazaki, S.; Nitta, H.; Kawamoto, T.; et al. Blood Mercury, Lead, Cadmium, Manganese and Selenium Levels in Pregnant Women and Their Determinants: The Japan Environment and Children’s Study (JECS). J. Expo. Sci. Environ. Epidemiol. 2019, 29, 633–647. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  44. Grau-perez, M.; Caballero-mateos, M.J.; Domingo-relloso, A.; Navas-acien, A.; Gomez-ariza, J.L.; Garcia-barrera, T.; Leon-latre, M.; Soriano-gil, Z.; Jarauta, E.; Cenarro, A.; et al. Toxic Metals and Subclinical Atherosclerosis in Carotid, Femoral, and Coronary Vascular Territories: The Aragon Workers Health Study. Arterioscler. Thromb. Vasc. Biol. 2022, 42, 87–99. [Google Scholar] [CrossRef] [PubMed]
  45. Yang, W.Y.; Zhang, Z.Y.; Thijs, L.; Cauwenberghs, N.; Wei, F.F.; Jacobs, L.; Luttun, A.; Verhamme, P.; Kuznetsova, T.; Nawrot, T.S.; et al. Left Ventricular Structure and Function in Relation to Environmental Exposure to Lead and Cadmium. J. Am. Heart Assoc. 2017, 6, 4692. [Google Scholar] [CrossRef] [Green Version]
  46. Landrigan, P.J.; Fuller, R.; Acosta, N.J.R.; Adeyi, O.; Arnold, R.; Basu, N.; Baldé, A.B.; Bertollini, R.; Bose-O’Reilly, S.; Boufford, J.I.; et al. The Lancet Commission on Pollution and Health. Lancet 2018, 391, 462–512. [Google Scholar] [CrossRef] [Green Version]
  47. WHO. Lead Poisoning and Health. Available online: https://www.who.int/news-room/fact-sheets/detail/lead-poisoning-and-health (accessed on 9 January 2020).
  48. Hegde, S.; Maysky, M.; Zaidi, A. A Rare Case of Lead-Induced Cardiomyopathy. JACC Case Rep. 2020, 2, 1496–1500. [Google Scholar] [CrossRef]
  49. Genchi, G.; Sinicropi, M.S.; Carocci, A.; Lauria, G.; Catalano, A. Mercury Exposure and Heart Diseases. Int. J. Environ. Res. Public Health 2017, 14, 74. [Google Scholar] [CrossRef] [Green Version]
  50. Katsnelson, B.A.; Klinova, S.V.; Gerzen, O.P.; Balakin, A.A.; Lookin, O.N.; Lisin, R.V.; Nabiev, S.R.; Privalova, L.I.; Minigalieva, I.A.; Panov, V.G.; et al. Force-Velocity Characteristics of Isolated Myocardium Preparations from Rats Exposed to Subchronic Intoxication with Lead and Cadmium Acting Separately or in Combination. Food Chem. Toxicol. 2020, 144, 111641. [Google Scholar] [CrossRef]
  51. Klinova, S.V.; Katsnelson, B.A.; Minigalieva, I.A.; Gerzen, O.P.; Balakin, A.A.; Lisin, R.V.; Butova, K.A.; Nabiev, S.R.; Lookin, O.N.; Katsnelson, L.B.; et al. Cardioinotropic Effects in Subchronic Intoxication of Rats with Lead and/or Cadmium Oxide Nanoparticles. Int. J. Mol. Sci. 2021, 22, 3466. [Google Scholar] [CrossRef]
  52. Kopp, S.J.; Bárány, M.; Erlanger, M.; Perry, E.F.; Perry, H.M. The Influence of Chronic Low-Level Cadmium and/or Lead Feeding on Myocardial Contractility Related to Phosphorylation of Cardiac Myofibrillar Proteins. Toxicol. Appl. Pharmacol. 1980, 54, 48–56. [Google Scholar] [CrossRef] [PubMed]
  53. Shemarova, I.V.; Korotkov, S.M.; Nesterov, V.P. Influence of Oxidative Processes in Mitochondria on Contractility of the Frog Rana Temporaria Heart Muscle. Effects of Cadmium. Zhurnal Evoliutsionnoi Biokhimii I Fiziol. 2011, 47, 306–310. [Google Scholar]
  54. Huang, Q.Y.; Fang, C.W.; Huang, H.Q. Alteration of Heart Tissue Protein Profiles in Acute Cadmium-Treated Scallops Patinopecten Yessoensis. Arch. Environ. Contam. Toxicol. 2011, 60, 90–98. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  55. Protsenko, Y.L.; Katsnelson, B.A.; Klinova, S.V.; Lookin, O.N.; Balakin, A.A.; Nikitina, L.V.; Gerzen, O.P.; Nabiev, S.R.; Minigalieva, I.A.; Privalova, L.I.; et al. Further Analysis of Rat Myocardium Contractility Changes Associated with a Subchronic Lead Intoxication. Food Chem. Toxicol. 2019, 125, 233–241. [Google Scholar] [CrossRef]
  56. Gerzen, O.P.; Nabiev, S.R.; Klinova, S.V.; Minigalieva, I.A.; Sutunkova, M.P.; Katsnelson, B.A.; Nikitina, L.V. Molecular Mechanisms of Mechanical Function Changes of the Rat Myocardium under Subchronic Lead Exposure. Food Chem. Toxicol. 2022, 169, 113444. [Google Scholar] [CrossRef]
  57. Fioresi, M.; Simões, M.R.; Furieri, L.B.; Broseghini-Filho, G.B.; Vescovi, M.V.A.; Stefanon, I.; Vassallo, D.V. Chronic Lead Exposure Increases Blood Pressure and Myocardial Contractility in Rats. PLoS ONE 2014, 9, e96900. [Google Scholar] [CrossRef] [Green Version]
  58. Haverinen, J.; Badr, A.; Vornanen, M. Cardiac Toxicity of Cadmium Involves Complex Interactions Among Multiple Ion Currents in Rainbow Trout (Oncorhynchus mykiss) Ventricular Myocytes. Environ. Toxicol. Chem. 2021, 40, 2874–2885. [Google Scholar] [CrossRef]
  59. Limaye, D.A.; Shaikh, Z.A. Cytotoxicity of Cadmium and Characteristics of Its Transport in Cardiomyocytes. Toxicol. Appl. Pharmacol. 1999, 154, 59–66. [Google Scholar] [CrossRef] [PubMed]
  60. Shen, J.; Wang, X.; Zhou, D.; Li, T.; Tang, L.; Gong, T.; Su, J.; Liang, P. Modelling Cadmium-Induced Cardiotoxicity Using Human Pluripotent Stem Cell-Derived Cardiomyocytes. J. Cell. Mol. Med. 2018, 22, 4221–4235. [Google Scholar] [CrossRef] [Green Version]
  61. Morad, M.; Maylie, J. Some Experimental Considerations. Chest 1980, 78, 166–173. [Google Scholar] [CrossRef]
  62. Vassallo, D.V.; Lebarch, E.C.; Moreira, C.M.; Wiggers, G.A.; Stefanon, I. Lead Reduces Tension Development and the Myosin ATPase Activity of the Rat Right Ventricular Myocardium. Braz. J. Med. Biol. Res. 2008, 41, 789–795. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  63. Ferreira de Mattos, G.; Costa, C.; Savio, F.; Alonso, M.; Nicolson, G.L. Lead Poisoning: Acute Exposure of the Heart to Lead Ions Promotes Changes in Cardiac Function and Cav1.2 Ion Channels. Biophys. Rev. 2017, 9, 807–825. [Google Scholar] [CrossRef] [Green Version]
  64. Moreira, C.M.; Oliveira, E.M.; Bonan, C.D.; Sarkis, J.J.F.; Vassallo, D.V. Effects of Mercury on Myosin ATPase in the Ventricular Myocardium of the Rat. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 2003, 135, 269–275. [Google Scholar] [CrossRef] [PubMed]
  65. Vassallo, D.V.; Moreira, C.M.; Oliveira, E.M.; Bertollo, D.M.; Veloso, T.C.; Vassallo, C.; Appl, T.C.T. Effects of Mercury on the Isolated Heart Muscle Are Prevented by DTT and Cysteine 1 Effects of Mercury on the Isolated Heart Muscle Are Prevented. Toxicol. Appl. Pharmacol. 1999, 118, 113–118. [Google Scholar] [CrossRef] [PubMed]
  66. Sa’idu, B.; Hassan, I.; Abdulazeez, N.; Aliyu, B.; Aliyu, B. Therapeutic Effect of Methanolic Leaves Extract of Cannabis in Copper Induced Cardio-Toxicity in Wistar Rats. Int. J. Pharmacogn. Life Sci. 2022, 3, 15–18. [Google Scholar] [CrossRef]
  67. Filetti, F.M.; Vassallo, D.V.; Fioresi, M.; Simões, M.R. Reactive Oxygen Species Impair the Excitation-Contraction Coupling of Papillary Muscles after Acute Exposure to a High Copper Concentration. Toxicol. Vitr. 2018, 51, 106–113. [Google Scholar] [CrossRef]
  68. Wang, R.; Wang, X.; Wu, L.; Mateescu, M. Toxic effects of cadmium and copper on the isolated heart of dogfish shark, squalus acanthias. J. Toxicol. Environ. Health Part A 2010, 57, 37–41. [Google Scholar]
  69. Lippmann, M.; Ito, K.; Hwang, J.S.; Maciejczyk, P.; Chen, L.C. Cardiovascular Effects of Nickel in Ambient Air. Environ. Health Perspect. 2006, 114, 1662–1669. [Google Scholar] [CrossRef] [Green Version]
  70. Chuang, H.C.; Hsueh, T.W.; Chang, C.C.; Hwang, J.S.; Chuang, K.J.; Yan, Y.H.; Cheng, T.J. Nickel-Regulated Heart Rate Variability: The Roles of Oxidative Stress and Inflammation. Toxicol. Appl. Pharmacol. 2013, 266, 298–306. [Google Scholar] [CrossRef]
  71. Campen, M.J.; Nolan, J.P.; Schladweiler, M.C.J.; Kodavanti, U.P.; Evansky, P.A.; Costa, D.L.; Watkinson, W.P. Cardiovascular and Thermoregulatory Effects of Inhaled PM-Associated Transition Metals: A Potential Interaction between Nickel and Vanadium Sulfate. Toxicol. Sci. 2001, 64, 243–252. [Google Scholar] [CrossRef] [Green Version]
  72. Shi, L.; Yuan, Y.; Xiao, Y.; Long, P.; Li, W.; Yu, Y.; Liu, Y.; Liu, K.; Wang, H.; Zhou, L.; et al. Associations of Plasma Metal Concentrations with the Risks of All-Cause and Cardiovascular Disease Mortality in Chinese Adults. Environ. Int. 2021, 157, 106808. [Google Scholar] [CrossRef] [PubMed]
  73. Paquette, T.; Clay, J.R.; Ogbaghebriel, A.; Shrier, A. Effects of Divalent Cations on the E-4031-Sensitive Repolarization Current, I(Kr), in Rabbit Ventricular Myocytes. Biophys. J. 1998, 74, 1278–1285. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  74. Alissa, E.M.; Ferns, G.A. Heavy Metal Poisoning and Cardiovascular Disease. J. Toxicol. 2011, 2011, 870125. [Google Scholar] [CrossRef] [PubMed]
  75. Sevim, Ç.; Doğan, E.; Comakli, S. Cardiovascular Disease and Toxic Metals. Curr. Opin. Toxicol. 2020, 19, 88–92. [Google Scholar] [CrossRef]
  76. Fatima, G.; Raza, A.M.; Hadi, N.; Nigam, N.; Mahdi, A.A. Cadmium in Human Diseases: It’s More than Just a Mere Metal. Indian J. Clin. Biochem. 2019, 34, 371–378. [Google Scholar] [CrossRef]
  77. Messner, B.; Bernhard, D. Cadmium and Cardiovascular Diseases: Cell Biology, Pathophysiology, and Epidemiological Relevance. BioMetals 2010, 23, 811–822. [Google Scholar] [CrossRef]
  78. Chen, X.; Cai, Q.; Liang, R.; Zhang, D.; Liu, X.; Zhang, M.; Xiong, Y.; Xu, M.; Liu, Q.; Li, P.; et al. Copper Homeostasis and Copper-Induced Cell Death in the Pathogenesis of Cardiovascular Disease and Therapeutic Strategies. Cell Death Dis. 2023, 14, 105. [Google Scholar] [CrossRef]
  79. Afridi, H.I.; Kazi, T.G.; Kazi, N.G.; Jamali, M.K.; Arain, M.B.; Sirajuddin; Baig, J.A.; Kandhro, G.A.; Wadhwa, S.K.; Shah, A.Q. Evaluation of Cadmium, Lead, Nickel and Zinc Status in Biological Samples of Smokers and Nonsmokers Hypertensive Patients. J. Hum. Hypertens. 2010, 24, 34–43. [Google Scholar] [CrossRef] [Green Version]
  80. Chanihoon, G.Q.; Afridi, H.I.; Kazi, T.G.; Talpur, F.N.; Baig, J.A. Evaluation of Zinc and Cadmium Levels in the Biological Samples of Ewing Sarcomas Patients and Healthy Subjects Clinica Chimica Acta Evaluation of Zinc and Cadmium Levels in the Biological Samples of Ewing Sarcomas Patients and Healthy Subjects. Clin. Chim. Acta 2021, 522, 1–7. [Google Scholar] [CrossRef]
  81. Lashari, A.; Afridi, H.I.; Kazi, T.G.; Talpur, F.N.; Baig, J.A.; Chanihoon, G.Q.; Channa, G.M. Interaction between Cadmium and Zinc Levels in the Biological Samples of Type 1 Diabetic Mellitus Children, Reside in Different Areas of Sindh, Pakistan. Am. J. Anal. Chem. 2021, 12, 241–259. [Google Scholar] [CrossRef]
  82. Yu, H.; Zhen, J.; Xu, J.; Cai, L.; Leng, J.; Ji, H.; Keller, B.B. Zinc Protects against Cadmium-Induced Toxicity in Neonatal Murine Engineered Cardiac Tissues via Metallothionein-Dependent and Independent Mechanisms. Acta Pharmacol. Sin. 2020, 41, 638–649. [Google Scholar] [CrossRef]
  83. Khalaf, Q.H.; Awad, N.A.N.; Hamadie, S.S. Determination the Relationship between Cadmium and Zinc Levels with Myocardial Infarction. Teikyo Med. J. 2022, 45, 5721–5728. [Google Scholar]
  84. Richardt, G.; Federolf, G.; Habermann, E. Affinity of Heavy Metal Ions to Intracellular Ca2+-Binding Proteins. Biochem. Pharmacol. 1986, 35, 1331–1335. [Google Scholar] [CrossRef]
  85. Thévenod, F.; Fels, J.; Lee, W.K.; Zarbock, R. Channels, Transporters and Receptors for Cadmium and Cadmium Complexes in Eukaryotic Cells: Myths and Facts. BioMetals 2019, 32, 469–489. [Google Scholar] [CrossRef]
  86. Rani, A.; Kumar, A.; Lal, A.; Pant, M. Cellular Mechanisms of Cadmium-Induced Toxicity: A Review. Int. J. Environ. Health Res. 2014, 24, 378–399. [Google Scholar] [CrossRef]
  87. Žikić, R.V.; Štajn, A.Š.; Ognjanović, B.I.; Saičić, Z.S.; Kostić, M.M.; Pavlović, S.Z.; Petrović, V.M. The Effect of Cadmium and Selenium on the Antioxidant Enzyme Activities in Rat Heart. J. Environ. Pathol. Toxicol. Oncol. 1998, 17, 259–264. [Google Scholar]
  88. Moulis, J.M. Cellular Mechanisms of Cadmium Toxicity Related to the Homeostasis of Essential Metals. BioMetals 2010, 23, 877–896. [Google Scholar] [CrossRef]
  89. Kirberger, M.; Yang, J.J. Structural Differences between Pb2+- and Ca2+-Binding Sites in Proteins: Implications with Respect to Toxicity. J. Inorg. Biochem. 2008, 102, 1901–1909. [Google Scholar] [CrossRef] [Green Version]
  90. Kirberger, M.; Wong, H.C.; Jiang, J.; Yang, J.J. Metal Toxicity and Opportunistic Binding of Pb2+ in Proteins. J. Inorg. Biochem. 2013, 125, 40–49. [Google Scholar] [CrossRef] [Green Version]
  91. Dudev, T.; Grauffel, C.; Lim, C. How Pb 2+ Binds and Modulates Properties of Ca2+ -Signaling Proteins. Inorg. Chem. 2018, 57, 14798–14809. [Google Scholar] [CrossRef]
  92. Gorkhali, R.; Huang, K.; Kirberger, M.; Yang, J.J. Defining Potential Roles of Pb2+ in Neurotoxicity from a Calciomics Approach. Metallomics 2016, 8, 563–578. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  93. Ordemann, J.M.; Austin, R.N. Lead Neurotoxicity: Exploring the Potential Impact of Lead Substitution in Zinc-Finger Proteins on Mental Health. Metallomics 2016, 8, 579–588. [Google Scholar] [CrossRef] [PubMed]
  94. Wyparło-Wszelaki, M.; Machoń-Grecka, A.; Wąsik, M.; Dobrakowski, M. Critical Aspects of the Physiological Interactions between Lead and Magnesium. J. Biochem. Mol. Toxicol. 2022, 36, e22964. [Google Scholar] [CrossRef]
  95. Jacobus, W.E.; Brierley, G.P. Ion Transport by Heart Mitochondria. J. Biol. Chem. 1969, 244, 4995–5004. [Google Scholar] [CrossRef]
  96. Hendrych, M.; Olejnickova, V.; Marie, N. Calcium versus Strontium Handling by the Heart Muscle. Gen. Physiol. Biophys. 2016, 35, 13–23. [Google Scholar] [CrossRef]
  97. Bongini, R.E.; Culver, S.B.; Elkins, K.M. Engineering Aluminum Binding Affinity in an Isolated EF-Hand from Troponin C: A Computational Site-Directed Mutagenesis Study. J. Inorg. Biochem. 2007, 101, 1251–1264. [Google Scholar] [CrossRef]
  98. Mujika, J.I.; Rezabal, E.; Mercero, J.M.; Ruipérez, F.; Costa, D.; Ugalde, J.M.; Lopez, X. Aluminium in Biological Environments: A Computational Approach. Comput. Struct. Biotechnol. J. 2014, 9, e201403002. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  99. Rezabal, E.; Mercero, J.M.; Lopez, X.; Ugalde, J.M. Protein Side Chains Facilitate Mg/Al Exchange in Model Protein Binding Sites. ChemPhysChem 2007, 8, 2119–2124. [Google Scholar] [CrossRef]
  100. Potocki, S.; Witkowska, D.; Pyrkosz, M.; Szebesczyk, A.; Krzywoszynska, K.; Kozlowski, H. Metal Transport and Homeostasis within the Human Body: Toxicity Associated with Transport Abnormalities. Curr. Med. Chem. 2012, 19, 2738–2759. [Google Scholar] [CrossRef]
  101. Goytain, A.; Quamme, G.A. Functional Characterization of Human SLC41A1, a Mg2+ Transporter with Similarity to Prokaryotic MgtE Mg2+ Transporters. Physiol. Genom. 2005, 21, 337–342. [Google Scholar] [CrossRef]
  102. Goytain, A.; Quamme, G.A. Functional Characterization of ACDP2 (Ancient Conserved Domain Protein), a Divalent Metal Transporter. Physiol. Genom. 2005, 22, 382–389. [Google Scholar] [CrossRef]
  103. Goytain, A.; Quamme, G.A. Functional Characterization of the Human Solute Carrier, SLC41A2. Biochem. Biophys. Res. Commun. 2005, 330, 701–705. [Google Scholar] [CrossRef]
  104. Goytain, A.; Quamme, G.A. Identification and Characterization of a Novel Family of Membrane Magnesium Transporters, MMgT1 and MMgT2. Am. J. Physiol. Cell Physiol. 2008, 294, 495–502. [Google Scholar] [CrossRef] [Green Version]
  105. Argüello, J.M. Identification of Ion-Selectivity Determinants in Heavy-Metal Transport P1B-Type ATPases. J. Membr. Biol. 2003, 195, 93–108. [Google Scholar] [CrossRef]
  106. Arguello, J.M.; Eren, E.; Gonza’lez-Guerrero, M. The Structure and Function of Heavy Metal Transport P 1B -ATPases. Biometals 2007, 20, 233–248. [Google Scholar] [CrossRef]
  107. Bridges, C.C.; Zalups, R.K. Molecular and Ionic Mimicry and the Transport of Toxic Metals. Toxicol. Appl. Pharmacol. 2005, 204, 274–308. [Google Scholar] [CrossRef] [Green Version]
  108. Hobai, I.A.; Bates, J.A.; Howarth, F.C.; Levi, A.J. Inhibition by External Cd2+ of Na/Ca Exchange and L-Type Ca Channel in Rabbit Ventricular Myocytes. Am. J. Physiol. Heart Circ. Physiol. 1997, 272, H2164–H2172. [Google Scholar] [CrossRef]
  109. Pignier, C.; Potreau, D. Characterization of Nifedipine-Resistant Calcium Current in Neonatal Rat Ventricular Cardiomyocytes. Am. J. Physiol. Heart Circ. Physiol. 2000, 279, 2259–2268. [Google Scholar] [CrossRef]
  110. Yu, H.T.; Zhen, J.; Leng, J.Y.; Cai, L.; Ji, H.L.; Keller, B.B. Zinc as a Countermeasure for Cadmium Toxicity. Acta Pharmacol. Sin. 2021, 42, 340–346. [Google Scholar] [CrossRef]
  111. Ferreira, G.; Yi, J.; Ríos, E.; Shirokov, R. Ion-Dependent Inactivation of Barium Current through L-Type Calcium Channels. J. Gen. Physiol. 1997, 109, 449–461. [Google Scholar] [CrossRef] [Green Version]
  112. Atchison, W.D. Effects of Toxic Environmental Contaminants on Voltage-Gated Calcium Channel Function: From Past to Present. J. Bioenerg. Biomembr. 2003, 35, 507–532. [Google Scholar] [CrossRef] [PubMed]
  113. Fernandes Azevedo, B.; Barros Furieri, L.; Peçanha, F.M.I.; Wiggers, G.A.; Frizera Vassallo, P.; Ronacher Simões, M.; Fiorim, J.; Rossi De Batista, P.; Fioresi, M.; Rossoni, L.; et al. Toxic Effects of Mercury on the Cardiovascular and Central Nervous Systems. J. Biomed. Biotechnol. 2012, 2012, 949048. [Google Scholar] [CrossRef] [Green Version]
  114. Sun, Q.; Li, Y.; Shi, L.; Hussain, R.; Mehmood, K.; Tang, Z.; Zhang, H. Heavy Metals Induced Mitochondrial Dysfunction in Animals: Molecular Mechanism of Toxicity. Toxicology 2022, 469, 153136. [Google Scholar] [CrossRef] [PubMed]
  115. Valko, M.; Morris, H.; Cronin, M.T.D. Glutathione-Heavy-Metal-1. Curr. Med. Chem. 2005, 12, 1161–1208. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  116. Gaburjakova, J.; Gaburjakova, M. The Cardiac Ryanodine Receptor Provides a Suitable Pathway for the Rapid Transport of Zinc (Zn2+). Cells 2022, 11, 868. [Google Scholar] [CrossRef]
  117. Lin, Z.; Wei, L.; Cai, W.; Zhu, Y.; Tucholski, T.; Mitchell, S.D.; Guo, W.; Ford, S.P.; Diffee, G.M.; Ge, Y. Simultaneous Quantification of Protein Expression and Modifications by Top-down Targeted Proteomics: A Case of the Sarcomeric Subproteome. Mol. Cell. Proteom. 2019, 18, 594–605. [Google Scholar] [CrossRef] [Green Version]
  118. Marchetti, C. Role of Calcium Channels in Heavy Metal Toxicity. ISRN Toxicol. 2013, 2013, 184360. [Google Scholar] [CrossRef] [Green Version]
  119. Wang, L.; Han, J.; Su, W.; Li, A.; Zhang, W.; Li, H.; Hu, H.; Song, W.; Xu, C.; Chen, J. Gut-on-a-Chip for Exploring the Transport Mechanism of Hg(II). Microsyst. Nanoeng. 2023, 9, 2. [Google Scholar] [CrossRef]
  120. Fujishiro, H.; Himeno, S. New Insights into the Roles of ZIP8, a Cadmium and Manganese Transporter, and Its Relation to Human Diseases. Biol. Pharm. Bull. 2019, 42, 1076–1082. [Google Scholar] [CrossRef] [Green Version]
  121. Au, C.; Benedetto, A.; Aschner, M. Manganese Transport in Eukaryotes: The Role of DMT1. Neurotoxicology 2008, 29, 569–576. [Google Scholar] [CrossRef] [Green Version]
  122. Herman, S.; Lipiñski, P.; Starzyñski, R.; Bednarz, A.; Grzmil, P.; Lenartowicz, M. Molecular Mechanisms of Cellular Copper Homeostasis in Mammals. Folia Biol. 2022, 70, 201–212. [Google Scholar] [CrossRef]
  123. Illing, A.C.; Shawki, A.; Cunningham, C.L.; Mackenzie, B. Substrate Profile and Metal-Ion Selectivity of Human Divalent Metal-Ion Transporter-1. J. Biol. Chem. 2012, 287, 30485–30496. [Google Scholar] [CrossRef] [Green Version]
  124. Vázquez, M.; Vélez, D.; Devesa, V.; Puig, S. Participation of Divalent Cation Transporter DMT1 in the Uptake of Inorganic Mercury. Toxicology 2015, 331, 119–124. [Google Scholar] [CrossRef] [PubMed]
  125. Tang, N.; Liu, X.; Jia, M.R.; Shi, X.Y.; Fu, J.W.; Guan, D.X.; Ma, L.Q. Amine- and Thiol-Bifunctionalized Mesoporous Silica Material for Immobilization of Pb and Cd: Characterization, Efficiency, and Mechanism. Chemosphere 2022, 291, 132771. [Google Scholar] [CrossRef]
  126. Krezel, A.; Lesniak, W.; Jezowska-Bojczuk, M.; Mlynarz, P.; Brasun, J.; Kozlowski, H.; Bal, W. Coordination of Heavy Metals by Dithiothreitol, a Commonly Used Thiol Group Protectant. J. Inorg. Biochem. 2001, 84, 77–88. [Google Scholar] [CrossRef]
  127. Xin, M.; Olson, E.N.; Bassel-Duby, R. Mending Broken Hearts: Cardiac Development as a Basis for Adult Heart Regeneration and Repair. Nat. Rev. Mol. Cell Biol. 2013, 14, 529–541. [Google Scholar] [CrossRef] [Green Version]
  128. Okamoto, Y.; Kawamura, K.; Nakamura, Y.; Ono, K. Pathological Impact of Hyperpolarization-Activated Chloride Current Peculiar to Rat Pulmonary Vein Cardiomyocytes. J. Mol. Cell. Cardiol. 2014, 66, 53–62. [Google Scholar] [CrossRef]
  129. Kaplan, J.H.; Maryon, E.B. How Mammalian Cells Acquire Copper: An Essential but Potentially Toxic Metal. Biophys. J. 2016, 110, 7–13. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  130. Pinnell, J.; Turner, S.; Howell, S. Cardiac Muscle Physiology. Contin. Educ. Anaesth. Crit. Care Pain 2007, 7, 85–88. [Google Scholar] [CrossRef] [Green Version]
  131. Denborough, M. Malignant Hyperthermia. Lancet 1998, 352, 1131–1136. [Google Scholar] [CrossRef] [PubMed]
  132. Yang, L.; Tautz, T.; Zhang, S.; Fomina, A.; Liu, H. The Current Status of Malignant Hyperthermia. J. Biomed. Res. 2020, 34, 75–85. [Google Scholar] [CrossRef]
  133. Murphy, E.; Steenbergen, C.; Levy, L.A.; Raju, B.; London, R.E. Cytosolic Free Magnesium Levels in Ischemic Rat Heart. J. Biol. Chem. 1989, 264, 5622–5627. [Google Scholar] [CrossRef]
  134. Borchgrevink, P.C.; Schie Bergan, A.; Bakoy, O.E.; Jynge, P. Magnesium and Reperfusion of Ischemic Rat Heart as Assessed by 31P-NMR. Am. J. Physiol. Heart Circ. Physiol. 1989, 256, H195–H204. [Google Scholar] [CrossRef]
  135. Johnson, C.J.; Peterson, D.R.; Smith, E.K. Myocardial Tissue Concentrations of Magnesium and Potassium in Men Dying Suddenly from Ischemic Heart Disease. Am. J. Clin. Nutr. 1979, 32, 967–970. [Google Scholar] [CrossRef]
  136. Lewit-bentley, A.; Réty, S. EF-Hand Calcium-Binding Proteins. Curr. Opin. Struct. Biol. 2000, 10, 637–643. [Google Scholar] [CrossRef]
  137. Snyder, E.E.; Buoscio, B.W.; Falke, J.J. Calcium(II) Site Specificity: Effect of Size and Charge on Metal Ion Binding to an EF-Hand-like Site. Biochemistry 1990, 29, 3937–3943. [Google Scholar] [CrossRef]
  138. Chao, S.H.; Bu, C.H.; Cheung, W.Y. Stimulation of Myosin Light-Chain Kinase by Cd2+ and Pb2+. Arch. Toxicol. 1995, 69, 197–203. [Google Scholar] [CrossRef]
  139. Chao, S.H.; Suzuki, Y.; Zysk, J.R.; Cheung, W.Y. Activation of Calmodulin by Various Metal Cations as a Function of Ionic Radius. Mol. Pharmacol. 1984, 26, 75–82. [Google Scholar] [PubMed]
  140. Vologzhannikova, A.A.; Shevelyova, M.P.; Kazakov, A.S.; Sokolov, A.S.; Borisova, N.I.; Permyakov, E.A.; Kircheva, N.; Nikolova, V.; Dudev, T.; Permyakov, S.E. Strontium Binding to α-Parvalbumin, a Canonical Calcium-Binding Protein of the “EF-Hand” Family. Biomolecules 2021, 11, 1158. [Google Scholar] [CrossRef] [PubMed]
  141. Siegel, N. Aluminum Interaction With Biomolecules: The Molecular Basis for Aluminum Toxicity. Am. J. Kidney Dis. 1985, 6, 353–357. [Google Scholar] [CrossRef] [PubMed]
  142. de Souza, I.D.; de Andrade, A.S.; Dalmolin, R.J.S. Lead-Interacting Proteins and Their Implication in Lead Poisoning. Crit. Rev. Toxicol. 2018, 48, 375–386. [Google Scholar] [CrossRef]
  143. Marston, S.; Zamora, J.E. Troponin Structure and Function: A View of Recent Progress. J. Muscle Res. Cell Motil. 2020, 41, 71–89. [Google Scholar] [CrossRef] [Green Version]
  144. Fuchs, F. Ion Exchange Properties of the Calcium Receptor Site of Troponin. Biochim. Biophys. Acta (BBA)-Bioenerg. 1971, 245, 221–229. [Google Scholar] [CrossRef]
  145. O’Connell, B.; Stephenson, D.G.; Blazev, R.; Stephenson, G.M.M. Troponin C Isoform Composition Determines Differences in Sr2+-Activation Characteristics between Rat Diaphragm Fibers. Am. J. Physiol. Cell Physiol. 2004, 287, 79–87. [Google Scholar] [CrossRef] [Green Version]
  146. Ma, W.; Nag, S.; Gong, H.; Qi, L.; Irving, T.C. Cardiac Myosin Filaments Are Directly Regulated by Calcium. J. Gen. Physiol. 2022, 154, 1–13. [Google Scholar] [CrossRef]
  147. Sitbon, Y.H.; Yadav, S.; Kazmierczak, K.; Szczesna-Cordary, D. Insights into Myosin Regulatory and Essential Light Chains: A Focus on Their Roles in Cardiac and Skeletal Muscle Function, Development and Disease. J. Muscle Res. Cell Motil. 2020, 41, 313–327. [Google Scholar] [CrossRef]
  148. Markandran, K.; Poh, J.W.; Ferenczi, M.A.; Cheung, C. Regulatory Light Chains in Cardiac Development and Disease. Int. J. Mol. Sci. 2021, 22, 4351. [Google Scholar] [CrossRef]
  149. Metzger, J.M.; Moss, R.L. Transitions in Vertebrate Skeletal Muscle. Biophys. J. 1992, 63, 460–468. [Google Scholar] [CrossRef] [Green Version]
  150. Falke, J.J.; Snyder, E.E.; Thatcher, K.C.; Voertler, C.S. Quantitating and Engineering the Ion Specificity of an EF-Hand-like Ca2+ Binding Site. Biochemistry 1991, 30, 8690–8697. [Google Scholar] [CrossRef]
  151. Da Silva, A.C.R.; Kendrick-Jones, J.; Reinach, F.C. Determinants of Ion Specificity on EF-Hands Sites: Conversion of the Ca2+/Mg2+ Site of Smooth Muscle Myosin Regulatory Light Chain into a Ca2+-Specific Site. J. Biol. Chem. 1995, 270, 6773–6778. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  152. Lu, Y.; Prudent, M.; Fauvet, B.; Lashuel, H.A.; Girault, H.H. Phosphorylation of α -Synuclein at Y125 and S129 Alters Its Metal Binding Properties: Implications for Understanding the Role of α -Synuclein in the Pathogenesis of Parkinson’s Disease and Related Disorders. ACS Chem. Neurosci. 2011, 2, 667–675. [Google Scholar] [CrossRef] [Green Version]
  153. Walker, B.C.; Walczak, C.E.; Cochran, J.C. Switch-1 Instability at the Active Site Decouples ATP Hydrolysis from Force Generation in Myosin II. Cytoskeleton 2021, 78, 3–13. [Google Scholar] [CrossRef]
  154. Polosukhina, K.; Eden, D.; Chinn, M.; Highsmith, S. CaATP as a Substrate to Investigate the Myosin Lever Arm Hypothesis of Force Generation. Biophys. J. 2000, 78, 1474–1481. [Google Scholar] [CrossRef] [Green Version]
  155. Ge, J.; Gargey, A.; Nesmelova, I.V.; Nesmelov, Y.E. CaATP Prolongs Strong Actomyosin Binding and Promotes Futile Myosin Stroke. J. Muscle Res. Cell Motil. 2019, 40, 389–398. [Google Scholar] [CrossRef]
  156. Baylor, S.M.; Hollingworth, S. Model of Sarcomeric Ca2+ Movements, Including ATP Ca2+ Binding and Diffusion, during Activation of Frog Skeletal Muscle. J. Gen. Physiol. 1998, 112, 297–316. [Google Scholar] [CrossRef] [Green Version]
  157. Tkachev, Y.V.; Ge, J.; Negrashov, I.V.; Nesmelov, Y.E. Metal Cation Controls Myosin and Actomyosin Kinetics. Protein Sci. 2013, 22, 1766–1774. [Google Scholar] [CrossRef] [Green Version]
  158. Bagshaw, C.R. The Kinetic Mechanism of the Manganous Ion-Dependent Adenosine Triphosphatase of Myosin Subfragment 1. FEBS Lett. 1975, 58, 197–201. [Google Scholar] [CrossRef] [Green Version]
  159. Peyser, Y.M.; Ben-hur, M.; Werber, M.M.; Muhlrad, A. Effect of Divalent Cations on the Formation and Stability of Myosin Subfragment 1—ADP—Phosphate Analog Complexes. Biochemistry 1996, 35, 4409–4416. [Google Scholar] [CrossRef] [PubMed]
  160. Burton, K.; White, H.; Sleep, J. Kinetics of Muscle Contraction and Actomyosin NTP Hydrolysis from Rabbit Using a Series of Metal-Nucleotide Substrates. J. Physiol. 2005, 563, 689–711. [Google Scholar] [CrossRef] [Green Version]
  161. Fioresi, M.; Furieri, L.B.; Simões, M.R.; Ribeiro Junior, R.F.; Meira, E.F.; Fernandes, A.A.; Stefanon, I.; Vassallo, D.V. Acute Exposure to Lead Increases Myocardial Contractility Independent of Hypertension Development. Braz. J. Med. Biol. Res. 2013, 46, 178–185. [Google Scholar] [CrossRef] [Green Version]
  162. Chizzonite, R.A.; Everett, A.W.; Prior, G.; Zak, R. Comparison of Myosin Heavy Chains in Atria and Ventricles from Hyperthyroid, Hypjthyroid and Euthyroid Rats. J. Biol. Chem. 1984, 259, 15564–15571. [Google Scholar] [CrossRef] [PubMed]
  163. Jones, D.L.; Kochian, L.V. Aluminum Interaction with Plasma Membrane Lipids and Enzyme Metal Binding Sites and Its Potential Role in Al Cytotoxicity. FEBS Lett. 1997, 400, 51–57. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  164. Cochran, J.C.; Zhao, Y.C.; Wilcox, D.E.; Kull, F.J. A Metal Switch for Controlling the Activity of Molecular Motor Proteins. Nat. Struct. Mol. Biol. 2012, 19, 122–128. [Google Scholar] [CrossRef] [PubMed]
  165. Cochran, J.C.; Thompson, M.E.; Kull, F.J. Metal Switch-Controlled Myosin II from Dictyostelium Discoideum Supports Closure of Nucleotide Pocket during ATP Binding Coupled to Detachment from Actin Filaments. J. Biol. Chem. 2013, 288, 28312–28323. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  166. Moher, D.; Liberati, A.; Tetzlaff, J.; Altman, D.G. Academia and Clinic Annals of Internal Medicine Preferred Reporting Items for Systematic Reviews and Meta-Analyses. Ann. Intern. Med. 2009, 151, 264–269. [Google Scholar] [CrossRef] [Green Version]
  167. Greenwood, N.; Arnshaw, A. Chemistry of the Elements. Radiochim. Acta 1996, 72, 1–6. [Google Scholar] [CrossRef]
  168. Quick, S.; Reuner, U.; Weidauer, M.; Hempel, C.; Heidrich, F.M.; Mues, C.; Sveric, K.M.; Ibrahim, K.; Reichmann, H.; Linke, A.; et al. Cardiac and Autonomic Function in Patients with Wilson’s Disease. Orphanet J. Rare Dis. 2019, 14, 1–6. [Google Scholar] [CrossRef] [Green Version]
Figure 1. Transport pathways for divalent cations in cardiomyocytes. The native divalent cations for the channels depicted in brown, non-native divalent cations that have been confirmed to enter cardiomyocytes through the channels indicated as grey. The size of the cations in the image corresponds to their effective ionic radius.
Figure 1. Transport pathways for divalent cations in cardiomyocytes. The native divalent cations for the channels depicted in brown, non-native divalent cations that have been confirmed to enter cardiomyocytes through the channels indicated as grey. The size of the cations in the image corresponds to their effective ionic radius.
Ijms 24 10579 g001
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Gerzen, O.P.; Votinova, V.O.; Potoskueva, I.K.; Tzybina, A.E.; Nikitina, L.V. Direct Effects of Toxic Divalent Cations on Contractile Proteins with Implications for the Heart: Unraveling Mechanisms of Dysfunction. Int. J. Mol. Sci. 2023, 24, 10579. https://doi.org/10.3390/ijms241310579

AMA Style

Gerzen OP, Votinova VO, Potoskueva IK, Tzybina AE, Nikitina LV. Direct Effects of Toxic Divalent Cations on Contractile Proteins with Implications for the Heart: Unraveling Mechanisms of Dysfunction. International Journal of Molecular Sciences. 2023; 24(13):10579. https://doi.org/10.3390/ijms241310579

Chicago/Turabian Style

Gerzen, Oksana P., Veronika O. Votinova, Iulia K. Potoskueva, Alyona E. Tzybina, and Larisa V. Nikitina. 2023. "Direct Effects of Toxic Divalent Cations on Contractile Proteins with Implications for the Heart: Unraveling Mechanisms of Dysfunction" International Journal of Molecular Sciences 24, no. 13: 10579. https://doi.org/10.3390/ijms241310579

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop